Real-world comparison of lisocabtagene maraleucel and axicabtagene ciloleucel in large B-cell lymphoma: an inverse probability of treatment weighting analysis with 3-year follow up

Lisocabtagene maraleucel (liso-cel) and axicabtagene ciloleucel (axi-cel) are FDA- and EMAapproved chimeric antigen receptor (CAR) T-cell therapies for relapsed/refractory large B-cell lymphoma (LBCL). However, comparative real-world analyses of their efficacy and toxicity with extended follow-up ar...

Celý popis

Uloženo v:

Podrobná bibliografie
Vydáno v:	Haematologica (Roma) Ročník 110; číslo 9; s. 2040 - 2054
Hlavní autoři:	Portuguese, Andrew J., Huang, Jennifer J., Jeon, Yein, Taheri, Mahnoosh, Albittar, Aya, Liang, Emily C., Hirayama, Alexandre V., Kimble, Erik L., Iovino, Lorenzo, Poh, Christina, Gopal, Ajay K., Shadman, Mazyar, Till, Brian G., Milano, Filippo, Chapuis, Aude G., Otegbeye, Folashade, Cassaday, Ryan D., Basom, Ryan S., Wu, Qian Vicky, Maloney, David G., Gauthier, Jordan
Médium:	Journal Article
Jazyk:	angličtina
Vydáno:	Italy Fondazione Ferrata Storti 01.09.2025 Ferrata Storti Foundation
Témata:	Adult Aged Aged, 80 and over Antigens, CD19 - therapeutic use Biological Products Cell Therapy & Immunotherapy Female Follow-Up Studies Humans Immunotherapy, Adoptive - adverse effects Immunotherapy, Adoptive - methods Lymphoma, Large B-Cell, Diffuse - drug therapy Lymphoma, Large B-Cell, Diffuse - immunology Lymphoma, Large B-Cell, Diffuse - mortality Lymphoma, Large B-Cell, Diffuse - pathology Lymphoma, Large B-Cell, Diffuse - therapy Male Middle Aged Receptors, Chimeric Antigen Retrospective Studies Tissue Extracts - adverse effects Tissue Extracts - therapeutic use Treatment Outcome
ISSN:	0390-6078, 1592-8721, 1592-8721
On-line přístup:	Získat plný text
Tagy:	Přidat tag Žádné tagy, Buďte první, kdo vytvoří štítek k tomuto záznamu!

Buďte první, kdo okomentuje tento záznam!